Deals round-up: AstraZeneca’s latest collaboration and Legal & General’s buy-in
Gowling WLG steered AstraZeneca through another significant deal last week, taking the lead for the pharmaceutical powerhouse on its $6bn cancer drug collaboration agreement with Daiichi Sankyo Company. As part of the agreement, AstraZeneca and Japan’s Daiichi will jointly develop and bring to market a cancer therapy drug in early clinical tests called DS-1062, a […]